{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:27:43Z","timestamp":1789993663512,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017009","name":"Institute of Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["DDR\/IIRP23\/3052"],"award-info":[{"award-number":["DDR\/IIRP23\/3052"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.abb.2024.110163","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:58:05Z","timestamp":1727107085000},"page":"110163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Niacin-induced flushing: Mechanism, pathophysiology, and future perspectives"],"prefix":"10.1016","volume":"761","author":[{"given":"Aaqib","family":"Javaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-0616","authenticated-orcid":false,"given":"Shyam Lal","family":"Mudavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11154-016-9394-8","article-title":"Flushing in (Neuro)Endocrinology","volume":"17","author":"Hannah-Shmouni","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11154-016-9394-8","article-title":"Flushing in (Neuro)Endocrinology","volume":"17","author":"Hannah-Shmouni","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"12","key":"10.1016\/j.abb.2024.110163_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0011-3840(89)90010-5","article-title":"Carcinoid tumors and the carcinoid syndrome","volume":"26","author":"Feldman","year":"1989","journal-title":"Curr. Probl. Surg."},{"key":"10.1016\/j.abb.2024.110163_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2016.05.003","article-title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus","volume":"47","author":"Singh","year":"2016","journal-title":"Cancer Treat Rev."},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum","volume":"39","author":"Boudreaux","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.abb.2024.110163_bib6","first-page":"8232","article-title":"Sustainable design of new ionic forms of vitamin B 3 and their utilization as plant protection agents","author":"Stachowiak","year":"2022","journal-title":"Cite This J. Agric. Food Chem"},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/clpt.1991.104","article-title":"Tolerance to nicotinic acid flushing","volume":"50","author":"Stern","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.abb.2024.110163_bib8","series-title":"Modern Nutrition in Health and Disease","author":"Ross","year":"2020"},{"key":"10.1016\/j.abb.2024.110163_bib9","article-title":"Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline","year":"1998","journal-title":"Diet. Ref. Intakes Thiamin, Riboflavin, Niacin, Vitam. B6, Folate, Vitam. B12, Pantothenic Acid, Biot. Choline"},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells","volume":"70","author":"Beny\u00f3","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1753-0407.2012.00216.x","article-title":"Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing","volume":"5","author":"Parson","year":"2013","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/039463200802100304","article-title":"A quercetin containing supplement reduces in niacin-induced flush in humans","volume":"21","author":"Kalogeromitros","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0773.1969.tb00530.x","article-title":"Comparison between the absorption of nicotinic acid and pentaerythritol tetranicotinate (Perycit\u00ae) from ordinary and enterocoated tablets","volume":"28","author":"Svedmyr","year":"1969","journal-title":"Acta Pharmacol. Toxicol."},{"issue":"4049","key":"10.1016\/j.abb.2024.110163_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/bmj.2.4049.346","article-title":"Treatment of pellagra with nicotinic acid","volume":"2","author":"Glueck","year":"1938","journal-title":"Br. Med. J."},{"issue":"9","key":"10.1016\/j.abb.2024.110163_bib15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/clpt.1991.104","article-title":"Tolerance to nicotinic acid flushing","volume":"50","author":"Stern","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9716","key":"10.1016\/j.abb.2024.110163_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.abb.2024.110163_bib18","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc13-2215","article-title":"Statins and the risk of diabetes: evidence from a large population-based cohort study","volume":"37","author":"Corrao","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.abb.2024.110163_bib19","series-title":"Labeling the Adenosine A 1 Receptor Using an Electrophilic Covalent Probe","article-title":"Chemical biological approach to study G protein-coupled receptors","author":"Beerkens","year":"2022"},{"issue":"7","key":"10.1016\/j.abb.2024.110163_bib20","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/jm300164q","article-title":"Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A)","volume":"55","author":"Blad","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110163_bib21","author":"Palani"},{"key":"10.1016\/j.abb.2024.110163_bib22","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1021\/jm100022r","article-title":"Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate","volume":"53","author":"Shen","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110163_bib23","author":"Blad"},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib24","first-page":"91","volume":"16","author":"Prousky","year":"2011","journal-title":"Pharmacologic Use of Niacin"},{"issue":"17","key":"10.1016\/j.abb.2024.110163_bib25","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2174\/1389557521666210125144921","article-title":"Novel niacin receptor agonists: a promising strategy for the treatment of dyslipidemia","volume":"21","author":"Kothawade","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0773.1999.tb01494.x","article-title":"Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man","volume":"84","author":"Saareks","year":"1999","journal-title":"Pharmacol. Toxicol."},{"issue":"17","key":"10.1016\/j.abb.2024.110163_bib27","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49536-y","article-title":"Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode","volume":"15","author":"Shenol","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-43537-z","article-title":"Orthosteric and allosteric modulation of human HCAR2 signaling complex","volume":"14","author":"Mao","year":"2023","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.abb.2024.110163_bib30","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.molcel.2023.07.030","article-title":"Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation","volume":"83","author":"Zhao","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.abb.2024.110163_bib31","doi-asserted-by":"crossref","unstructured":"Yadav, M. K.; Sarma, P.; Maharana, J.; Ganguly, M.; Mishra, S.; Zaidi, N.; Dalal, A.; Singh, V.; Saha, S.; Mahajan, G.; Sharma, S.; Chami, M.; Banerjee, R.; Shukla, A. K. Structure-Guided Engineering of Biased-Agonism in the Human Niacin Receptor via Single Amino Acid Substitution. https:\/\/doi.org\/10.1038\/s41467-024-46239-2.","DOI":"10.1038\/s41467-024-46239-2"},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s42255-024-00997-x","article-title":"Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia","volume":"6","author":"Membrez","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.abb.2024.110163_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172871","article-title":"Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects","volume":"868","author":"Jiang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.abb.2024.110163_bib34","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1021\/acs.jcim.1c00893","article-title":"TRPV1 activation by anandamide via a unique lipid pathway","volume":"61","author":"Muller","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/SLA.0b013e3182a6359c","article-title":"Transient receptor potential ion channels: powerful regulators of cell function","volume":"259","author":"Billeter","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.abb.2024.110163_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.632711","article-title":"The underlying mechanism of modulation of transient receptor potential melastatin 3 by protons","volume":"12","author":"Hossain Saad","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/j.2040-4603.2013.tb00486.x","article-title":"Molecular mechanism of TRP channels","volume":"3","author":"Zheng","year":"2013","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib38","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/ATVBAHA.113.303346","article-title":"Nicotinic acid activates the capsaicin receptor TRPV1: potential mechanism for cutaneous flushing","volume":"34","author":"Ma","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9149(98)00448-2","article-title":"Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia","volume":"82","author":"Guyton","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.abb.2024.110163_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.160.8.1177","article-title":"Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol","volume":"160","author":"Guyton","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"11","key":"10.1016\/j.abb.2024.110163_bib41","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/hq1001.096624","article-title":"Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol","volume":"21","author":"Sakai","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib42","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1194\/jlr.M700426-JLR200","article-title":"Niacin inhibits surface expression of ATP synthase \u03b2 chain in HepG2 cells: implications for raising HDL","volume":"49","author":"Zhang","year":"2008","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.abb.2024.110163_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0026-0495(98)90284-0","article-title":"Equivalent efficacy of a time-release form of niacin (niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia","volume":"47","author":"Knopp","year":"1998","journal-title":"Metabolism"},{"issue":"21","key":"10.1016\/j.abb.2024.110163_bib44","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.abb.2024.110163_bib45","doi-asserted-by":"crossref","unstructured":"NiAc Formulation. https:\/\/doi.org\/10.1194\/jlr.M068395.","DOI":"10.1194\/jlr.M068395"},{"key":"10.1016\/j.abb.2024.110163_bib46","first-page":"407","volume":"54","author":"Offermanns","year":"2014","journal-title":"Free Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors"},{"issue":"10","key":"10.1016\/j.abb.2024.110163_bib47","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","article-title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells","volume":"45","author":"Ganji","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.abb.2024.110163_bib48","series-title":"Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE\u22173Leiden","author":"Van Der Hoorn","year":"2016"},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0021-9150(77)90201-5","article-title":"Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid","volume":"28","author":"Carlson","year":"1977","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.abb.2024.110163_bib50","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1001\/jama.1987.03390230069027","article-title":"Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts","volume":"257","author":"Blankenhorn","year":"1987","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.abb.2024.110163_bib51","first-page":"1583","volume":"345","author":"Brown","year":"2001","journal-title":"Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease"},{"issue":"23","key":"10.1016\/j.abb.2024.110163_bib52","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.abb.2024.110163_bib53","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima\u2013media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib54","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-142-2-200501180-00008","article-title":"A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events","volume":"142","author":"Whitney","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.abb.2024.110163_bib56","doi-asserted-by":"crossref","unstructured":"Kamanna, V. S.; Ganji, S. H.; Kashyap, M. L. The Mechanism and Mitigation of Niacin-Induced Flushing. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02099.x.","DOI":"10.1111\/j.1742-1241.2009.02099.x"},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1520-037X.2006.04736.x","article-title":"\u201cFlush-Free niacin\u201d: dietary supplement may Be \u201cbenefit-free.\u201d","volume":"9","author":"Norris","year":"2006","journal-title":"Prev. Cardiol."},{"issue":"12","key":"10.1016\/j.abb.2024.110163_bib58","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7326\/0003-4819-139-12-200312160-00009","article-title":"Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia","volume":"139","author":"Meyers","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jacl.2008.02.004","article-title":"Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 Mg monotherapy: the SEACOAST II (High-Dose) study","volume":"2","author":"Ballantyne","year":"2008","journal-title":"J. Clin. Lipidol."},{"issue":"10","key":"10.1016\/j.abb.2024.110163_bib60","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.amjcard.2008.02.092","article-title":"Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study)","volume":"101","author":"Ballantyne","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00129784-200808020-00001","article-title":"Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study","volume":"8","author":"Karas","year":"2008","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"24","key":"10.1016\/j.abb.2024.110163_bib62","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials","volume":"24","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.abb.2024.110163_bib63","first-page":"613","article-title":"Ultradeformable nanoparticles for active targeting of microbial infections: a photothermal approach","author":"Javaid","year":"2024","journal-title":"Nanophototherapy"},{"issue":"20","key":"10.1016\/j.abb.2024.110163_bib64","first-page":"3977","article-title":"Formulation and in vitro evaluation of niacinloaded nanoparticles to reduce prostaglandin mediated vasodilatory flushing","volume":"19","author":"Cooper","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","article-title":"Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective \u03b2-adrenergic blocker","volume":"67","author":"Hsu","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.abb.2024.110163_bib66","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/IJN.S245326","article-title":"Recent progress and future directions: the nano-drug delivery system for the treatment of Vitiligo","volume":"15","author":"Sun","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.abb.2024.110163_bib67","author":"Radwan-Prag\u0142owska"},{"key":"10.1016\/j.abb.2024.110163_bib68","author":"Wang"},{"key":"10.1016\/j.abb.2024.110163_bib69","first-page":"454","article-title":"Niacin-loaded liquid crystal nanoparticles ameliorate prostaglandin D2-mediated niacin-induced flushing and hepatotoxicity","volume":"7","author":"Javaid","year":"2024","journal-title":"Cite This ACS Appl. Nano Mater"},{"issue":"5","key":"10.1016\/j.abb.2024.110163_bib70","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-024-02812-y","article-title":"Transdermal delivery of niacin through polysaccharide films ameliorates cutaneous flushing in experimental wistar rats","volume":"25","author":"Javaid","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.abb.2024.110163_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","article-title":"Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: a potential clinical auxiliary diagnostic marker","volume":"230","author":"Wang","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.abb.2024.110163_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2021.06.028","article-title":"A potential objective marker in first-episode schizophrenia based on abnormal niacin response","volume":"243","author":"Hu","year":"2022","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib73","article-title":"Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis","volume":"35","author":"Gan","year":"2022","journal-title":"Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.abb.2024.110163_bib74","article-title":"Artificial intelligence-assisted niacin skin flush screening in early psychosis identification and prediction","volume":"35","author":"Chen","year":"2022","journal-title":"Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.abb.2024.110163_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9061848","article-title":"SKINREMS\u2014a new method for assessment of the niacin skin flush test response in schizophrenia","volume":"9","author":"Karakula-Juchnowicz","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.abb.2024.110163_bib76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/schbul\/sbr054","article-title":"A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia","volume":"39 1","author":"Lien","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.abb.2024.110163_bib77","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/schbul\/sbx150","article-title":"Identification of the niacin-blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population","volume":"44","author":"Sun","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.abb.2024.110163_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051879","article-title":"Niacin skin flush backs\u2014from the roots of the test to nowadays hope","volume":"12","author":"Sitarz","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.abb.2024.110163_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jad.2009.12.017","article-title":"Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder","volume":"124 3","author":"Smesny","year":"2010","journal-title":"J. Affect. Disord."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T20:00:48Z","timestamp":1745611248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":79,"alternative-id":["S0003986124002856"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110163","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niacin-induced flushing: Mechanism, pathophysiology, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110163"}}